N-21.AI INDIA PRIVATE LIMITED

What N-21.AI INDIA PRIVATE LIMITED does

N-21.AI India Private Limited (DBA N-21.ai) is a privately held, India-incorporated company founded in 2025 that builds the Chiral AI agentic platform for regulated healthcare, with an initial focus on Medicare Advantage risk adjustment. The company sells to Medicare Advantage health plans, integrated payer-provider systems, risk-bearing entities, MSOs, ACOs, CINs, and providers who need audit-defensible documentation rather than faster coding alone.

Chiral AI ingests clinical notes, charts, claims, and encounter data and applies CMS-aligned models to extract conditions, link each diagnosis to underlying evidence (notes, labs, reports), validate documentation against MEAT criteria, flag unsupported diagnoses, and generate structured audit-ready artifacts for RADV and internal reviews. The platform is built on a proprietary architecture that separates reasoning, learning, and execution into inspectable layers, evaluates decisions against versioned policy logic, and maintains end-to-end lineage and bidirectional explainability graphs so any decision can be reconstructed. Product offerings include the core Chiral risk adjustment product plus specialized modules — Chiral RA (payer-facing risk adjustment), Provider-Facing Documentation, and Integrated Payer-Provider Orchestration. Deployment is non-disruptive, integrating via secure data pipelines and APIs without requiring EHR integration.

The company runs an enterprise field sales motion with quote-based annual SaaS subscriptions, targeting U.S. healthcare buyers from a Noida delivery hub and U.S. remote presence, supported by HIPAA compliance and SOC 2 Type II certification (under observation). Marketing is content-driven through the N-21 Insights blog, LinkedIn, and demo/contact request funnels. The founder & CEO is Shreesh Tiwari; no funding rounds, revenue figures, or institutional investors are disclosed in available sources.

Name

N-21.AI INDIA PRIVATE LIMITED

Legal name

N-21.AI INDIA PRIVATE LIMITED

Website

https://n-21.ai

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

N-21.ai (N-21.AI India Private Limited) builds the Chiral AI agentic platform for Medicare Advantage risk adjustment, linking every diagnosis to clinical evidence with MEAT validation and audit-defensible documentation for U.S. health plans, providers, and risk-bearing entities.

Ownership category

akta.pro rank

Product category

Healthcare AI Risk Adjustment Software

NAICS

Software Publishers (5132), Computer Systems Design Services (541512)

SIC

Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

Regulatory Readiness & Audit Automation (e.g., EU AI Act, NIST AI RMF, ISO/IEC 42001) (HDAAAMAE)

akta.pro secondary industries

Enterprise AI Governance, Risk & Compliance Platforms (Model Risk, Audit, Policies) (HDAEANAE), Audit, Explainability & Accountability Tooling (traceability, reporting) (HDAAAKAL), AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs) (HDAEANAJ)

Keywords

• Healthcare AI platform
• Medicare risk adjustment
• Clinical documentation intelligence
• Audit-defensible coding
• Payer-provider orchestration

Headquarters

HQ city

Princeton

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Chiral AI Platform Subscription: SaaS-based AI platform licensing for Medicare Advantage risk adjustment and clinical documentation intelligence. The platform is offered through enterprise agreements with implementation, training, and ongoing support services.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

N-21.ai designs, develops, and deploys the Chiral AI agentic AI platform for regulated healthcare, with an initial focus on Medicare Advantage risk adjustment and clinical documentation. The platform ingests charts, claims, and clinical documents; applies CMS-aligned AI models; links every diagnosis to verifiable clinical evidence and MEAT criteria; flags unsupported codes; and produces audit-ready artifacts and explainable insights for payers and providers.

Product overview

N-21.AI builds agentic AI for regulated healthcare, starting with Medicare Advantage risk adjustment. The company offers a unified platform architecture centered on the Chiral AI platform, which serves as the foundational technology layer. Built on this platform are product offerings including Chiral (the core risk adjustment product) and specialized solution modules including Chiral RA (payer-facing risk adjustment), Provider-Facing Documentation, and Integrated Payer-Provider Orchestration. These products work together to provide end-to-end audit-defensible documentation intelligence, enabling healthcare organizations to link diagnoses to clinical evidence, validate against MEAT criteria, and generate audit-ready artifacts across the risk adjustment lifecycle.

Differentiator

Problem solved

Functional benefit

Brands

• Chiral AI: The company's agentic AI platform for healthcare risk adjustment, enabling audit-defensible documentation for Medicare Advantage organizations.

Products and services

• Chiral AI Platform An agentic AI platform that orchestrates risk, care, and cost for healthcare organizations. The platform ingests clinical documentation, applies CMS-aligned AI models, and produces explainable insights with full audit traceability. Built for healthcare payer and provider organizations managing Medicare Advantage risk adjustment programs.
• Chiral The risk adjustment product built on the Chiral AI platform. Creates audit-defensible RAF scores by linking every diagnosis to verifiable clinical evidence and MEAT criteria. Identifies missed conditions, flags audit-vulnerable charts, and generates structured evidence bundles for RADV and internal audits.
• Chiral RA (Payer-Facing Risk Adjustment) Risk adjustment module connecting to existing chart, claim, and document sources to evaluate every submitted diagnosis against MEAT requirements. Flags unsupported conditions, links each code to underlying clinical evidence, and provides operations and compliance teams with a single defensible view of risk across full member populations.
• Provider-Facing Documentation Solution Point-of-care documentation solution that surfaces risk adjustment intelligence so providers can document defensibly without changing their workflows. Identifies missing MEAT elements, unsupported diagnoses, and documentation gaps while the encounter is still active, delivering timely clinically grounded prompts.
• Integrated Payer-Provider Orchestration Solution Coordination solution acting as a common intelligence layer for integrated delivery networks and payer-provider partnerships. Maintains a single, evidence-linked view of each member's conditions, documentation status, and RAF impact that both plan and provider stakeholders can access and act on together.

Quantifiable outcome

• 5:1 Return on AI investment
• +6 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature7 records

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Cotiviti: Large incumbent in payment integrity and risk adjustment for payers and providers. Broader portfolio than N-21.ai but directly competes for the same Medicare Advantage risk adjustment and audit defensibility budget.
• Optum (Risk Adjustment): UnitedHealth Group's health services arm offering risk adjustment analytics, coding, and audit support as part of a broader enterprise services portfolio. Competes with N-21.ai for MA plan risk adjustment spend.

Direct peers

• Apixio: Risk adjustment and clinical analytics platform (owned by Centene) that processes clinical documentation to support HCC capture and audit defensibility for Medicare Advantage plans. Direct overlap with Chiral's core RAF use case.
• Cohere Health: AI-driven clinical intelligence platform spanning prior authorization, risk adjustment, and care management for health plans. Competes directly with N-21.ai in the same payer buyer segment with overlapping explainability and audit-grade positioning.
• Anterior: AI-native prior authorization and risk adjustment platform for health plans. Direct competitor in applying LLM-based clinical reasoning to payer workflows with explainability, comparable to Chiral's Medicare Advantage focus.

Emerging players

• Arcadia: Healthcare data platform with risk adjustment, HCC capture, and value-based care analytics. Adjacent competitor serving risk-bearing entities and ACOs, a core N-21.ai target segment.
• Edifecs: Healthcare data interoperability and compliance platform with risk adjustment and audit-related modules. Comparable focus on regulatory alignment and explainable AI for payer workflows.
• Innovaccer: Healthcare data activation platform with risk adjustment, population health, and care management modules. India-based engineering presence, comparable vertical SaaS approach, and overlapping payer-provider customer segments.

Others

• Health Catalyst:
• Clareto (formerly RecordFlow):

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/n-21-ai

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about N-21.AI INDIA PRIVATE LIMITED